Hazard
17 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Of the 17 stability testing recalls we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 0 (0%) are Severe.
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all stability testing recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
GSMS Niacin Extended-Release Tablets, USP, 1,000 mg, are being recalled after a lot was out of specification for stage 3 dissolution at the 24-hour timepoint. 2,961 bottles affected.
Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, are being recalled after an out-of-specification dissolution result at the ninth month of testing. 360 bottles affected.
Lannett Niacin Extended-release Tablets, 1,000 mg, are being recalled after a stability test returned an out-of-specification low result for Stage 3 dissolution at 24 hours.
Taro is recalling one lot of Fluocinonide 0.05% Cream after stability testing returned out-of-specification viscosity results above the specification limit. 24,672 tubes are affected.
Taro is recalling one lot of Fluocinonide 0.05% Cream in 60 g tubes after stability testing returned viscosity results above the specification limit. 2,640 tubes are affected.
Taro is recalling one lot of Fluocinonide 0.05% Cream in 30 g tubes after stability testing returned viscosity results above the specification limit. 41,712 tubes are affected.
Cipla USA is recalling three lots of Nilotinib Capsules 150 mg after out-of-specification results in description and visual appearance testing at six-month long-term stability.
Cipla USA is recalling one lot of Nilotinib Capsules 200 mg after out-of-specification results in description and visual appearance testing at six-month long-term stability.
Epinephrine Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL vials compounded by Imprimis NJOF are being recalled because of subpotent assay results during stability testing. 6,880 vials affected.
A compounded Tropicamide-Proparacaine-Phenylephrine-Ketorolac sterile ophthalmic solution is being recalled because of subpotent assay results during stability testing. 2,890 vials are affected.
NingBo Huize Commodity Co., Ltd. is recalling ICEE Peach Scented Antibacterial Hand Gel because stability testing was not conducted on the product.
NingBo Huize Commodity Co., Ltd. is recalling DOTS Scented Antibacterial Hand Gel Orange because stability testing was not conducted on the product.
NingBo Huize Commodity Co., Ltd. is recalling CHARMS Blow Pop Scented Antibacterial Hand Gel because stability testing was not conducted on the OTC products.
NingBo Huize Commodity Co., Ltd. is recalling Dubble Bubble Scented Antibacterial Hand Gel because stability testing was not conducted on the product.
NingBo Huize Commodity Co., Ltd. is recalling ICEE Blue Raspberry Scented Antibacterial Hand Gel because stability testing was not conducted on the product.
NingBo Huize Commodity Co., Ltd. is recalling CHARMS Blow Pop Cherry Scented Antibacterial Hand Gel because stability testing was not conducted on the product.
NingBo Huize Commodity Co., Ltd. is recalling Dots Scented Antibacterial Hand Gel because stability testing was not conducted on the product.